Real-World Safety and Effects of FOQUEST for ADHD
About this title
Read the official source — NCT04152629Researchers compared Methylphenidate Hydrochloride and Lisdexamfetamine Dimesylate to find out how the approaches affected ADHD symptoms in children with ADHD.
Understand this study
What did researchers investigate?
Researchers compared Methylphenidate Hydrochloride and Lisdexamfetamine Dimesylate to find out how the approaches affected ADHD symptoms in children with ADHD.
Who was this study for?
This study was for people with ADHD. Listed age limits: from 6 years. Other eligibility criteria applied.
- Listed locations
- Calgary and 11 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 257
- Sponsor
- Purdue Pharma, Canada
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- Over 6 Years
- Official registry ID
- NCT04152629
- Official title
Show the full official title
A Phase IV, Real World, Open-label, Multi-centre Study on the Use of FOQUEST® (Methylphenidate Hydrochloride Controlled-release Capsules) for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Pediatric and Adult Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Calgary · Burnaby · Ajax
6 more locations
- Chatham
- Etobicoke
- Greater Sudbury
- Ottawa
- Windsor
- Québec
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Methylphenidate Hydrochloride and Lisdexamfetamine Dimesylate to find out how the approaches affected ADHD symptoms in children with ADHD.
Who is behind this study?
The study sponsor is Purdue Pharma, Canada, a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate Hydrochloride and Lisdexamfetamine Dimesylate.
Who was this study for?
This study was for people with ADHD. Listed age limits: from 6 years. Other eligibility criteria applied.
